Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells.

Authors:
Lotfi M; Morshedi Rad D; Mashhadi SS; Ashouri A; Mojarrad M and 6 more

Journal:
Stem Cell Rev Rep

Publication Year: 2023

DOI:
10.1007/s12015-023-10585-3

PMCID:
PMC10661828

PMID:
37723364

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Stem Cell Rev Rep

Abbreviation: Stem Cell Rev Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cell Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Activation of MG53 Enhances Cell Survival and Engraftment of Human Induced Pluripotent Stem Cell-De…
Park KH; He X; Jiang L and 4 more (2023) - Transparency Score: 3/6
APEX1 Nuclease and Redox Functions are Both Essential for Adult Mouse Hematopoietic Stem and Progen…
Zaunz S; De Smedt J; Lauwereins L and 7 more (2023) - Transparency Score: 4/6
Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype-phenotype Correlation and Pathop…
Fan X; Yang G; Duru F and 5 more (2023) - Transparency Score: 3/6
Cell Therapy for Androgenetic Alopecia: Elixir or Trick?
Mao Y; Liu P; Wei J and 4 more (2023) - Transparency Score: 3/6
Dbx2, an Aging-Related Homeobox Gene, Inhibits the Proliferation of Adult Neural Progenitors.
Giuliani A; Licursi V; Nisi PS and 7 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics Approval and Consent to ParticipateNot applicable. Consent for PublicationNot applicable. Competing InterestsThe authors have not disclosed any competing interests. Competing Interests The authors have not disclosed any competing interests."

Evidence found in paper:

"Fundings Open Access funding enabled and organized by CAUL and its Member Institutions"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025